XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Loans Payable
12 Months Ended
Jun. 30, 2021
Notes to Financial Statements  
Loans Payable to Affiliates [Text Block]
5.
LOANS PAYABLE:
 
Pennvest
 
PA1,
the Company's wholly-owned subsidiary, owes
$9,868,495
as of
June 30, 2021
under the terms of the Pennvest Loan related to the construction of the Kreider
1
System including accrued interest and late charges totaling
$2,114,495
as of
June 30, 2021.
The terms of the Pennvest Loan provided for funding of up to
$7,754,000
which was to be repaid by interest-only payments for
three
years, followed by an additional
ten
-year amortization of principal. The Pennvest Loan accrues interest at
2.547%
per annum for years
1
through
5
and
3.184%
per annum for years
6
through maturity. The Pennvest Loan required minimum annual principal payments of approximately
$5,886,000
in fiscal years
2013
through
2021,
and
$846,000
in fiscal year
2022,
$873,000
in fiscal year
2023
and
$149,000
in fiscal year
2024.
The Pennvest Loan is collateralized by the Kreider
1
System and by a pledge of all revenues generated from Kreider
1
including, but
not
limited to, revenues generated from nutrient reduction credit sales and by-product sales. In addition, in consideration for the excess credit risk associated with the project, Pennvest is entitled to participate in the profits from Kreider
1
calculated on a net cash flow basis, as defined. The Company has incurred interest expense related to the Pennvest Loan of
$246,887
and
$246,887
for the years ended
June 30, 2021
and
2020,
respectively. Based on the limited development of the depth and breadth of the Pennsylvania nutrient reduction credit market to date,
PA1
commenced negotiations with Pennvest related to forbearance and/or re-structuring the obligations under the Pennvest Loan. In the context of such negotiations,
PA1
elected
not
to make interest payments to Pennvest on the Pennvest Loan since
January 2013.
Additionally, the Company has
not
made any principal payments, which were to begin in fiscal
2013,
and, therefore, the Company has classified the Pennvest Loan as a current liability as of
June 30, 2021.
 
On
September 25, 2014,
Pennvest exercised its right to declare the Pennvest Loan in default and accelerated the Pennvest Loan and demanded that
PA1
pay
$8,137,117
(principal, interest plus late charges) on or before
October 24, 2014.
PA1
did
not
make the payment and does
not
have the resources to make the payments demanded by Pennvest.
PA1
commenced discussions and negotiations with Pennvest concerning this matter but Pennvest rejected
PA1's
proposal made during the fall of
2014.
PA1
made a new proposal to Pennvest during
September 2021
which proposal is presently under consideration by Pennvest.
PA1
provides Pennvest with its financial statements (which include a description of system status) annually. During the
2021
fiscal year, Pennvest's auditors requested a ‘corrective action plan' and
PA1
informed Pennvest that “… there is
no
viable corrective action plan for the Pennvest Loan (‘Loan'). The facility funded by the Loan has been shut down for many years (which has been disclosed in the annual financial reports to Pennvest and in public filings by the parent of Bion PA
1,
LLC) and the technology utilized in the facility is now obsolete. The facility has
not
been commercially operated for approximately
six
years and has generated
zero
income. We recommend that Pennvest take appropriate steps to remove and sell the equipment.”  Pennvest responded favorably to the approach of selling the equipment but
no
actions have yet taken place.
PA1
and the Company are currently discussing proposals with Pennvest seeking full resolution of these matters.  The Company anticipates additional communication with Pennvest on this matter during the current year. It is
not
possible at this date to predict the final outcome of this matter, but the Company believes it is likely that that the equipment will be sold with the proceeds delivered to Pennvest during the
2022
fiscal year. However, the  resolution of these matters including  the manner and means of such equipment sale has
not
been agreed upon as of this date.
PA1
will evaluate the appropriate manner to resolve/wrap-up its business over the balance of the current fiscal year.
 
In connection with the Pennvest Loan financing documents, the Company provided a ‘technology guaranty' regarding nutrient reduction performance of Kreider
1
which was structured to expire when Kreider
1's
nutrient reduction performance had been demonstrated. During
August 2012
the Company provided Pennvest (and the PADEP) with data demonstrating that the Kreider
1
System had surpassed the requisite performance criteria and that the Company's ‘technology guaranty' was met. As a result, the Pennvest Loan is solely an obligation of
PA1.
 
Paycheck Protection Program
 
During the year ended
June 30, 2020,
the Company received proceeds from a loan in the amount of
$34,800
from Covenant Bank as the lender, pursuant to the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act. The loan was uncollateralized, had a fixed interest rate of
one
percent, a term of
two
years and the
first
payment is deferred for
six
months. Under the CARES Act, borrowers were eligible for forgiveness of principal and interest on PPP loans to the extent that the proceeds were used to cover eligible payroll costs, rent and utility costs over either an
8
or
24
-week period after the loan was made. As of
June 30, 2021,
the total PPP loan and accrued interest was fully forgiven by the SBA.